We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Measuring Heart Toxicity of Cancer Drugs

News   Mar 24, 2017 | Original story from NCI

 
Measuring Heart Toxicity of Cancer Drugs

A stem cell-derived heart muscle cell. Proteins that are important for muscle cell contraction are highlighted in red and green, and cell nuclei are blue. Credit: Joseph C. Wu, M.D., Ph.D., Stanford Cardiovascular Institute

 
 
Advertisement
 

RELATED ARTICLES

Gut-Directed Astrocytes Dampen Inflammation in the Brain

News

Evidence has shown that astrocytes can also actively promote neurodegeneration, inflammation, and neurological diseases. Now, a team has shown that a specific astrocyte sub-population can do the opposite, instead serving a protective, anti-inflammatory function based on signals regulated by the bacteria that reside in the gut.

READ MORE

Cross Reactivity Seen Between SARS-CoV-2 and Antibodies to 2003 SARS Outbreak Virus

News

A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa.

READ MORE

FDA Approves Vericiguat for Use in Patients With Heart Failure

News

The US Food and Drug Administration (FDA) has approved the cardiovascular drug vericiguat. The drug is a once-daily oral treatment for patients with worsening chronic heart failure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE